Paclitaxel drug-eluting vascular stents

DESs have been the most recent breakthrough in stent technology. DESs consist of a metal stent covered with a thin polymer coating designed to improve vascular compatibility and elute antiproliferative agents. Drugs such as sirolimus (rapamycin) and paclitaxel serve to reduce restenosis by reducing hyperplasia caused by smooth muscle cell proliferation [37, 38]. 

---